Top

Netherlands Heart Journal

Published in:

Open Access 01-06-2016 | Editor’s Comment

Pulmonary hypertension: the importance of a multidisciplinary approach

Authors: M. C. Post, E. E. van der Wall

Published in: Netherlands Heart Journal | Issue 6/2016

Excerpt

In this special issue of the Netherlands Heart Journal different aspects of pulmonary hypertension are elucidated. …

Galiè N, Humbert M, Vachiery J‑L, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2015;2016(37):67–119.

Simonneau G, Galiè N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):5S–12S.CrossRefPubMed

Post MC. Association between pulmonary hypertension and an atrial septal defect. Neth Heart J. 2013;21:331–332.CrossRefPubMedCentralPubMed

Huitema MP, Grutters JC, Rensing BJ, Reesink HJ, Post MC. Pulmonary hypertension complicating pulmonary sarcoidosis. Neth Heart J. 2016. DOI: 10.1007/s12471-016-0847-1CrossRefPubMedPubMedCentral

Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med. 2007;28:233–241.CrossRefPubMed

Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30:104–109.CrossRefPubMed

Engelfriet PM, Duffels MGJ, Möller T, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart. 2007;93:682–687.CrossRefPubMed

Blok IM, Riel ACMJ van, Schuuring MJ, et al. Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease. Neth Heart J. 2015;23:278–284.CrossRefPubMedCentralPubMed

Post MC, Mager JJ. Quality of life in pulmonary arterial hypertension. Neth Heart J. 2015;23:275–277.CrossRefPubMedCentralPubMed

10.

Wapenaar M, Twiss J, Wagenaar M, et al. Adaptation and validation of the Cambridge Pulmonary Hypertension Review (CAMPHOR) for the Netherlands. Neth Heart J. 2016. DOI: 10.1007/s12471-016-0849-z.CrossRefPubMedPubMedCentral

11.

Twiss J, McKenna S, Ganderton L, et al. Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension. BMC Pulm Med. 2013;13:45.CrossRefPubMedCentralPubMed

12.

Baggen V, Driessen M, Post M, et al. Echocardiographic findings associated with mortality or transplant in patients with pulmonary hypertension: A systematic review and meta-analysis. Neth Heart J. 2016. DOI: 10.1007/s12471-016-0845-3.CrossRefPubMedPubMedCentral

13.

Schölzel BE, Snijder RJ, Mager JJ, et al. Chronic thromboembolic pulmonary hypertension. Neth Heart J. 2014;22:533–541.CrossRefPubMedCentralPubMed

14.

Riel A van, Schuuring MJ, Hessen ID van, et al. Pulmonary arterial hypertension treatment in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome. Neth Heart J. 2016. DOI: 10.1007/s12471-016-0820-z.CrossRefPubMedPubMedCentral

15.

Wu W‑H, Yang L, Peng F‑H, et al. Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;187:303–310.CrossRefPubMedCentralPubMed

16.

Couperus L, Henkens I, Jongbloed M, Hazekamp M, Schalij M, Vliegen H. Tailored circulatory intervention in adults with pulmonary hypertension due to congenital heart disease. Neth Heart J. 2016. doi:10.1007/s12471-016-0820-z.CrossRefPubMedPubMedCentral

17.

Baumgartner H, Bonhoeffer P, Groot NMS De, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–2957.CrossRefPubMed

Title: Pulmonary hypertension: the importance of a multidisciplinary approach
Authors: M. C. Post
E. E. van der Wall
Publication date: 01-06-2016
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 6/2016
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-016-0848-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Pulmonary hypertension: the importance of a multidisciplinary approach

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2016

A case highly suspicious of isolated cardiac sarcoidosis

Pulmonary hypertension complicating pulmonary sarcoidosis

Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome

Echocardiographic findings associated with mortality or transplant in patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Regular pulse rate but irregular heart rate?

Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page